OVA Conjugated Anandamide (AEA)
OVA Conjugated Anandamide (AEA) is a purified Conjugated Small Molecules. Purity: >90% by SDS-PAGE. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Universal. Target Name: Anandamide (AEA) . Target Synonyms: N-Arachidonoylethanolamine. Theoretical MW: 347.5Da. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
OVA Conjugated Anandamide (AEA) is a purified Conjugated Small Molecules.
Expression System
Protein Conjugation
Target
Anandamide (AEA)
Conjugation
OVA
Applications
Immunogen, SDS-PAGE, WB
Endotoxin
<1.0EU/ug, by the LAL method
Purity
>90% by SDS-PAGE
Activity
Not Tested
Format
Freeze-dried powder
Buffer
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
347.5da
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
N-Arachidonoylethanolamine
Species
Universal
Protein Name
Conjugated Small Molecules
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Urokinase Plasminogen Activator (PLAU, plasminogen activator, urokinase, HGNC:9052, ATF, UPA, URK, u-PA , U-plasminogen activator, antagonist of uPA, plasminogen activator, urinary, urokinase plasminogen activator, urokinase-type plasminogen activator amino-terminal fragment, urokinase-type plasminogen activator precursor) (MaxLight 490) discontinued